Royal Bank Of Canada Poly Pid Ltd. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.34 - $0.45 $23 - $31	70 Added 90.91%	147 $0
Q4 2022 Feb 14, 2023	BUY	$0.66 - $38.7 $46 - $2,709	70 Added 1000.0%	77 $0
Q3 2022 Nov 14, 2022	SELL	$1.06 - $36.9 $238 - $8,302	-225 Reduced 96.98%	7 $0
Q2 2022 Aug 15, 2022	SELL	$4.35 - $5.76 $543 - $720	-125 Reduced 35.01%	232 $1,000
Q1 2022 May 16, 2022	BUY	$3.92 - $6.25 $1,399 - $2,231	357 New	357 $2,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $59.2M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.